Michael D. Wortley's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 807 Class A common stock done at an average price of $169.0 . Disclosure was reported to the exchange on Aug. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 169.04 per share. | 15 Aug 2023 | 807 | 50,099 (0%) | 0% | 169.0 | 136,415 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 168.76 per share. | 15 Aug 2023 | 398 | 49,701 (0%) | 0% | 168.8 | 67,167 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 4,125 | 50,906 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 84.81 per share. | 15 May 2023 | 894 | 47,198 (0%) | 0% | 84.8 | 75,816 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 80.99 per share. | 15 May 2023 | 417 | 46,781 (0%) | 0% | 81.0 | 33,773 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 84.46 per share. | 07 Mar 2023 | 414 | 48,092 (0%) | 0% | 84.5 | 34,966 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 87.57 per share. | 03 Mar 2023 | 2,169 | 48,506 (0%) | 0% | 87.6 | 189,939 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 63,650 | 63,650 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 15,675 | 50,675 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 70,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 35,000 | 35,000 (0%) | 0% | 0 | Class A common stock | |
| Pioneer Natural Resources Co. | Michael D. Wortley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 1,456 | 11,626 (0%) | 0% | 0 | Common Stock | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 16,500 | 16,500 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | 11 Nov 2020 | 51,429 | 51,429 (0%) | 0% | - | Class A common stock | ||
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | 11 Nov 2020 | 51,429 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 39,184 | 0 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 39,184 | 51,429 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 179.05 per share. | 11 Nov 2020 | 16,608 | 21,133 (0%) | 0% | 179.0 | 2,973,623 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 12,245 | 12,245 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 12,245 | 0 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 180.24 per share. | 11 Nov 2020 | 10,552 | 10,581 (0%) | 0% | 180.2 | 1,901,916 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 178.10 per share. | 11 Nov 2020 | 9,386 | 37,741 (0%) | 0% | 178.1 | 1,671,617 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 180.93 per share. | 11 Nov 2020 | 7,971 | 2,610 (0%) | 0% | 180.9 | 1,442,159 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 177.24 per share. | 11 Nov 2020 | 2,190 | 47,127 (0%) | 0% | 177.2 | 388,157 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 175.94 per share. | 11 Nov 2020 | 2,112 | 49,317 (0%) | 0% | 175.9 | 371,592 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 182.06 per share. | 11 Nov 2020 | 2,100 | 510 (0%) | 0% | 182.1 | 382,323 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 182.64 per share. | 11 Nov 2020 | 410 | 100 (0%) | 0% | 182.6 | 74,883 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Michael D. Wortley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 184.00 per share. | 11 Nov 2020 | 100 | 0 (0%) | 0% | 184 | 18,400 | Class A common stock |